相关实验视频
Updated: Jul 23, 2025

05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
6.2K
一个ankyrin重复的陪伴者在amyloidogenesis过程中准有毒的寡合体
Arpit Gupta1, Chuqi Lu1, Feng Wang2
1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California, USA.
Protein science : a publication of the Protein Society
|July 11, 2023
概括
一种植物伴侣,cpSRP43,有效地延迟与阿尔茨海默氏症和帕金森症相关的蛋白质聚合. 这种脚蛋白重复域 (ARD) 伴侣对生物工程治疗策略对抗与年龄相关的神经退行性疾病有前途.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 蛋白质错误折叠和聚合是许多与年龄有关的疾病的标志,包括阿尔茨海默病和帕金森病.
- 目前的治疗策略集中在针对蛋白质聚合物的小分子和抗体上.
- 一种替代方法涉及利用分子陪伴者,特别是那些具有可设计的支架,如膜重复域 (ARD).
研究的目的:
- 为了研究cpSRP43的潜力,一种来自植物的ARD伴侣,以抑制与疾病相关的蛋白质聚合.
- 阐明cpSRP43对抗蛋白质聚合的机制.
- 在神经退行性疾病的细胞模型中评估cpSRP43的治疗疗效.
主要方法:
- 生物化学测试用于监测蛋白质聚合动力学.
- 动态建模以了解伴侣互动的机制.
- 使用神经元细胞进行细胞测试,以评估对蛋白质聚合物毒性的保护.
- 对cpSRP43基质结合域的结构功能分析.
主要成果:
- cpSRP43显著延迟了粉样β (Aβ) 和α-synuclein的聚合.
- 动力分析显示,cpSRP43的向是Aβ的早期寡合物种,防止纤维的形成.
- 鉴定出cpSRP43的基林重复域 (ARD) 是其抗聚合活性的重要组成部分.
- cpSRP43通过从Aβ42诱导的毒性中拯救神经元细胞来证明神经保护作用.
结论:
- cpSRP43是一种基于ARD的植物伴侣,对与阿尔茨海默氏症和帕金森病相关的蛋白质表现出强大的抗聚合活性.
- cpSRP43的ARD支架足以防止Aβ聚合,并提供细胞保护.
- 这项研究突出了非哺乳动物ARD陪伴者的潜力,用于生物工程对抗蛋白质错折疾病的治疗干预.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Molecular Chaperones and Protein Folding
18.0K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
18.0K
Export of Misfolded Proteins out of the ER
3.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K
Bacterial Protein Maturation
36
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
36
Protein Folding Quality Check in the RER
3.8K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.8K
Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K

